Dermatomyositis (DM) is a rare, autoimmune muscle and skin disease that can also affect the heart, lungs, and other organs of the body.
DM is one of several types of the Idiopathic Inflammatory Myopathies. The term “idiopathic” means no known cause.
, , Dermatomyositis, Featured, News, Video
Dr. Victoria Werth joined us live online for a video education session titled, "Skin findings seen with myositis autoantibodies...
DETERMINE - a Phase 3 trial designed to evaluate the efficacy and safety of lenabasum for the treatment of adults...
, , Dermatomyositis, Featured, News
New locations announced July 9, 2019. DETERMINE is a double-blind, placebo-controlled 1-year study designed to test the efficacy and...
, , Dermatomyositis, Featured, News
The research found that DM patients with the anti-transcriptional intermediary factor 1 (anti-TIF1) antibody were more than three times...
"New Developments on the Role of Itch in Dermatomyositis", based on new research published in the British Journal of...
Dr. Victoria Werth, MD, presents, "Overview and new developments in Dermatomyositis." This was a live Myositis Support and Understanding...
Chronic Illness, Myositis, and Depression: The following are the comments I gave to a support group about my book,...
Did you know there are doctors who have combined training in both Dermatology and Rheumatology? These physicians are referred...
Dermatomyositis is a rare autoimmune disease, occurring in only 5-10 people per million, which is caused by the body’s...
Expert Care at Cass Regional Medical Center Story of Tim Lee, Dermatomyositis patient The fall of 2008 marked the...
© 2020 Myositis Support and Understanding Association (MSU). All rights reserved. | View our Privacy Policy, Terms, and Non-Discrimination policy
MSU is a charitable organization with 501(c)(3) tax-exempt status. Federal ID #47-4570748.
Send this to a friend
